chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician and a medical assistant concerning a 5 year old boy with no pertinent medical history and no history of drug reaction or allergies, weight 43lb, height 44 inches, who on 16-Jun-2004 was vaccinated SQ with the first dose VARIVAX (Merck) (lot number not provided). On 19-May-2008 the patient was vaccinated SQ in the right arm with his second dose of VARIVAX (Merck) (Lot # 660043/1858U). There was no concomitant medication. At the time of injection of the second dose, the patient moved his arm. On 19-MAY-2008 the patient developed edema, redness and pain at injection site in the right arm. On 20-MAY-2008 the patient sought medical attention with a physician office visit. He was seen by the physician when the swelling reportedly increased. After 24 hours, the patient recovered. The reporter stated that she was not sure if the patient had any type of raection after the first dose since that dose was not given at their office. Additional information is not expected.
On the day after my vaccine, my back started hurting me.  I went to an orthopedist, who prescribed Tylenol. That night, my back was so painful I could not bend over to pick something up.  Transitioning from sitting to standing and vice versa was excruciating pain. The next day, the back pain was no longer there.  It was definitely a side effect to the Moderna vaccine I had the day before.
Saturday morning October 25, 2014, started having rigors and chills. At night on Saturday was unable to move or get out of bed due to body aches, and other symptoms lasted until Sunday morning.
Drew up and injected adult dose into pediatric patient, no adverse outcomes according to parent, called and spoke with parent on 11/18 after identifying error.
pt recvd vax; pt exp diarrhea, a sore neck & pain that extended back to her left arm;
3hr post vax sleepy, would not walk or move, did not want to be touched, lips/eyes swollen-unhappy, T102.5, eyes open/close/rolling;cried hysterically x3hr;slowly began to recover;did not eat much;rx motrin;
On June 7, patient developed pox-vesicular spots on face, head and buttocks which crusted over in 5 days. On June 9, patient developed localized reaction at site characterized by a hard, red, bluish area 2" in diameter. Lidocaine spray decreased the redness.
This spontaneous report was received from a physician via company representatives and from a support services director concerning to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications was not reported. On 05-JAN-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, "10PK-0.5ml SD-PFS LLok wTip" which had the lot # K009874 with expiration date 19-MAR-2016 (dosage number and route of administration were not reported). On an unspecified dates, the vaccine had two temperature excursions; one for 48 hours in which the lowest recorded temperature was 34 degrees Fahrenheit (1.111111111 degrees Celsius) and another one for 40 hours in which the highest recorded temperature was 47 degrees Fahrenheit (8.333333333 degrees Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported and no product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
patient had enormous pain over her entire body, she could not hold food down, she could not sit or lay down .  She went to the emergency room that evening, vitals were OK, no fever,  she was not dehydrated.  ER treated the event like a migraine.  On Sunday 5/9 at about 10pm all the symptoms broke and she felt fine.  She reported she had no problem with the first dose.
Shaking, chills, dysesthesia, no fever X 8 weeks--still unresolved; labile HTN; absent deep tendon reflexes; possible modified GBS;
The next morning, patient was fatigued to the point that he could not do much and slept most of the day. Saturday afternoon, mild discomfort in shoulder muscles started. Sunday morning spams in left shoulder were severe.  It was like a Charley horse because the pain and muscle tightness was incredible. Used cold/warm compresses and massaged area to release the muscle tightness; also took Aleve. The muscles occurred if moved head/neck in a certain way.   On Monday could not handle normal activities and could not even get to sleep.  Called doctor on Tuesday afternoon and he prescribed Flexeril along with Aleve. Diagnosed with Torticolis and Cervical Dystonia. The medicine along with hot/cold compresses and massages relieved some of the pain and loosened up muscle tissue.  Today, spams not as frequent but still cannot move head up or turn left since certain movements trigger the spams again. Doctor provided referral for physical therapy and patient will start this afternoon.
1st dose on 29Sep2022, 2nd on 10Nov2022/ Administering the Second Dose of Shingrix at Less than the Minimum Recommended Interval; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 59-year-old male patient who received Herpes zoster (Shingrix) (batch number AR335, expiry date 11th February 2024) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On 10th November 2022, the patient received the 2nd dose of Shingrix. On 10th November 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional Information: GSK Receipt Date: 14-NOV-2022 Reporter's comments: The nurse had called to report that the patient who was not immunocompromised patient had received his first dose on 29 September 2022, lot number-23YG7 and expiration date 10 December 2023. but then, on 10 November 2022 he was administered with a Shingrix second dose. The reporter had consent to follow up via email. Additional supportive information: The patient had received the second dose earlier than the recommended interval, which led to shortening of vaccination schedule.
Received 2 vaccines and a booster.  On 12/28/21 developed headache, fatigue, cough.  Home  Positive antigen test for COVID
10 minutes after receiving dose developed lightheaded and dizzy. No LOC or fall. Responded to prone position and oral fluids Vital signs remained normal
chills; felt bad; going to be sick to her stomach; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), MALAISE (felt bad) and ABDOMINAL DISCOMFORT (going to be sick to her stomach) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016b21a and 025a2119) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included lisinpril, METOPROLOL, meloxigan and ATORVASTATIN CALCIUM (ATORVASTIN) for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced CHILLS (chills), MALAISE (felt bad) and ABDOMINAL DISCOMFORT (going to be sick to her stomach). At the time of the report, CHILLS (chills), MALAISE (felt bad) and ABDOMINAL DISCOMFORT (going to be sick to her stomach) outcome was unknown.            No treatment medications were provided
Tuesday evening my entire body was inflamed. All my joints were in so much pain.  This continued for 2 days straight.  I felt  sick for many days after.   My body aches, mild cough and headache. On Friday I went to the Urgent Care.  They tested me for Covid, Flu, and Strep.  All negative. The Dr said it seems to be a reaction to the vaccine. Saturday I woke up with a fever of 100.5. I did a virtual urgent care visit.   The Dr told me is seems to be a reaction to the vaccine or possibly a virus so he gave me Augmentin and benzonate for the cough.  Sunday morning I woke up with a fever of 101.5 and I started coughing badly.   Last night I had a fever of 102. Today I am still sick with body aches, headache, terrible cough and joint pain.   I called pharmacy to confirm they gave me the Flu vaccine and not the Covid vaccine because the joint pain and feeling sick is how I felt after I took the Covid vaccine. They confirmed they gave me the flu vaccine.
Patient reported full body rash and facial swelling after the 15 minute waiting period was complete. 5 days later, patient still has full body rash.
Pt. given Pneumovax Lt. deltoid 10-30-07, 10-31-07 developed 4cm x 4cm induration Lt. deltoid, erythema, Lt anterior neck, total body rash, no fever
Slight fever; Slight nausea; This is a spontaneous report from a contactable consumer or other non-health care professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: Not reported), via an unspecified route of administration on an unspecified date as unknown, single for COVID-19 immunization. It was unknown whether the patient was pregnant or not. The patient medical history and concomitant medications were not reported. The patient experienced slight fever and slight nausea for 1 day on an unspecified date. It was unknown if patient received other vaccines in four weeks, if COVID prior vaccination treatment details and if COVID tested post vaccination. The patient made the comment on social media (replied to one of reporter's facebook posts) and the reporter does not know the actual date of the events. The patient underwent lab tests and procedures which included body temperature: Slight fever on an unspecified date of 2021. The treatment details and clinical outcome of events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
face was tingly; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient. A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 15:00 (Lot number: EW0151) at the age of 36 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hearing loss" (unspecified if ongoing); "PNC" (unspecified if ongoing); "Latex" (unspecified if ongoing). Concomitant medication included: TYLENOL. Past drug history included: Aspirin, reaction: "Allergy Aspirin". The following information was reported: PARAESTHESIA (non-serious) with onset 31Mar2021, outcome "not recovered", described as "face was tingly". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of paraesthesia.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Reported Event: 30 minutes after first shot, face was tingly for 24 hours. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment with 4 Claritin a day. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vac-cination, the patient has been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
The pt presented to health department on 8/28/2001 with a complaint of redness, swelling and itching. The pt's onset of symptoms were on 8/25/01. Symptoms noted on left deltoid and upper arm. Pt sent to family MD for evaluation.
Initial report received on 01 February 2010 from the mother of the patient. A 2 year 6 month old female child received a left deltoid intramuscular injection of FLUZONE (lot number U3350AA) and a left deltoid intramuscular injection of H1N1 (lot number UP053AA) on 29 January 2010. On an unspecified date within 4 weeks prior, she had received a right deltoid intramuscular injection of VAQTA (Merck lot number 1397Y). On 30 January 2010 the patient's mother noted the child was "pointing to different body parts (chest, arms, legs)" and stating it felt "picky." There were no signs of a rash or redness in the areas where the child was pointing. The patient had no illness at the time of the vaccine and no known allergies. She had a medical history of a sinus infection. Cefdinir was a concomitant medication. It was unknown if the child recovered. Documents held by sender: None.
Intestinal cramps; Diarrhea; Felt like flu; Hand and feet were cold; Face felt hot; This spontaneous case was reported by a patient and describes the occurrence of GASTROINTESTINAL PAIN (Intestinal cramps), DIARRHOEA (Diarrhea), INFLUENZA LIKE ILLNESS (Felt like flu), PERIPHERAL COLDNESS (Hand and feet were cold) and FEELING HOT (Face felt hot) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced GASTROINTESTINAL PAIN (Intestinal cramps), DIARRHOEA (Diarrhea), INFLUENZA LIKE ILLNESS (Felt like flu), PERIPHERAL COLDNESS (Hand and feet were cold) and FEELING HOT (Face felt hot). The patient was treated with BISMUTH SUBSALICYLATE at an unspecified dose and frequency. At the time of the report, GASTROINTESTINAL PAIN (Intestinal cramps), DIARRHOEA (Diarrhea), INFLUENZA LIKE ILLNESS (Felt like flu), PERIPHERAL COLDNESS (Hand and feet were cold) and FEELING HOT (Face felt hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is taking other medications.  Treatment medications included Pepto bismol (Bismuth subsalicylate).
Patient tolerated injection well, ambulated to waiting room, after approximately 5 min, customer came to clinic room 1, patient was laying on floor, assisted by mom, did not hit head, no injuries noted, pale, A/O x 4, patient stood up and tried to leave, layed down flat BP 92/60, patient ambulated to exam room 2, reclined back with feet elevated, drinking water, states had similar experience with last injection at health department, did not disclose, after about 10 min, states fells good, no concerns, refusing additional vitals, caregiver present for transport, no distress noted
Systemic: Body Aches Generalized-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Tingling fingertips-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: A couple of minutes after the shot, the patient said he had a sharp neck pain. He sat down and then said he felt hot all over except his arms which were tingling/numb. Patient was clearly very anxious and said he felt "odd," and he asked me to call his wife and appeared to be having a panic attack. It lasted about 10 minutes, and at 13 minutes post vaccine, patient said it had passed. He seemed fine when he left after his 15 minutes and said over and over he did not want me to call an ambulance.
Swelling of left arm and left side of upper torso. Painful sensitivity to touch. No fever
Vagal episode Feeling unwell, dizzy vomiting, felt faint, nausea Onset of symptoms within 15 minutes of injection Symptoms persisted - Zofran ODT given in office. Family member called to drive patient home Nausea continues ~ 2 weeks after administration - now ? gastritis - started on PPI for acid suppression
approx 12 hrs p/receiving immun pt had large forceful emesis & stopped breathing 30-60 seconds; placed on bed by IA had another forceful emesis & another apneic spell lasting 60 sec; turned blue, CPR started by family;
round rash at site of injection approximately 1.5 (quotation mark); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 23Oct2023 at 14:30 as dose 1, single (Batch/Lot number: unknown) at the age of 75 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN, Batch/ Lot number not reported), for COVID-19 Immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN, Batch/ Lot number not reported), for COVID-19 Immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN, Batch/ Lot number not reported), for COVID-19 Immunization; Covid-19 vaccine (DOSE 4; MANUFACTURER UNKNOWN, Batch/ Lot number not reported), for COVID-19 Immunization; Covid-19 vaccine (DOSE 5; MANUFACTURER UNKNOWN, Batch/ Lot number not reported), for COVID-19 Immunization; Covid-19 vaccine (DOSE 6; MANUFACTURER UNKNOWN, Batch/ Lot number not reported), for COVID-19 Immunization. The following information was reported: VACCINATION SITE RASH (non-serious) with onset 24Oct2023 at 06:30, outcome "not recovered", described as "round rash at site of injection approximately 1.5 (quotation mark)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vaccination site rash.  Additional Information: The patient had no other vaccine in four weeks. Other medications in two weeks reported: thyroid supplement, multivitamin, vitamin D, fish. The patient had no known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient stated that she had a funny taste in her mouth and tingly; refused benadryl; left store and says when she got home cheek were red and it was painful in her mouth still refused benadryl warned if got worse to go to er
she had the symptoms of COVID after the vaccination; This is a spontaneous report from a contactable consumer, the patient received via a Pfizer-sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (Pfizer-Biontech COVID-19 mRNA vaccine, solution for injection) via an unspecified route of administration on 10Mar2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient had 1st dose of Pfizer COVID-19 vaccine last Wednesday which was 10Mar2021 and she had the symptoms of COVID after the vaccination. Now she was asking if how long the symptoms would last. The outcome for the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pain began in both my shoulders and neck. As it intensified it spread throughout my body: down my left arm into my wrist, to my back and hip area (i have had issues here for 20 years), into my knees and ankles and into my left calf muscle. Further, it gave me a bad headache. i was so uncomfortable I got very little sleep that night. It continues into the following day and didn't begin to subside until about 4:00 pm. The pain in my left shoulder and arm continued off and on until today, 03/19/2021, and was at it's worst when laying down and first thing in the morning upon waking up.
Information has been received from a health professional "that heard of" a patient (age unknown), who, on an unspecified date, was vaccinated with a dose of GARDASIL.  Subsequently, the patient experienced temporary paralysis of her legs.  At the time of the report, the outcome of the patient was unknown.  No product quality complaint was involved.  Upon internal review temporary paralysis of her legs was considered to be an other important medical event.  This is one of two reports from the same source.  Additional information has been requested.
This case was reported by a other health professional via call center representative and described the occurrence of therapy non-responder in a adult female patient who received TWINRIX (batch number AHABB251AA, expiry date 30th May 2014) for prophylaxis. Co-suspect products included TWINRIX (batch number AHABB251AA, expiry date 30th May 2014) for prophylaxis, TWINRIX (batch number AHABB251AA, expiry date 30th May 2014) for prophylaxis and HEPATITIS B VACCINE for prophylaxis. On 13th November 2012, the patient received the 1st dose of TWINRIX. On 14th December 2012, the patient received the 2nd dose of TWINRIX. On 14th May 2013, the patient received the 3rd dose of TWINRIX. In February 2014, the patient received HEPATITIS B VACCINE. In June 2018, unknown after receiving TWINRIX, TWINRIX and TWINRIX, the patient experienced therapy non-responder and hepatitis b antibody negative. On an unknown date, the patient experienced therapy non-responder and hepatitis b antibody negative. On an unknown date, the outcome of the therapy non-responder, hepatitis b antibody negative, therapy non-responder and hepatitis b antibody negative were unknown. It was unknown if the reporter considered the therapy non-responder, hepatitis b antibody negative, therapy non-responder and hepatitis b antibody negative to be related to TWINRIX, TWINRIX and TWINRIX. Additional details were provided as follows: This case was reported by the office manager. The healthcare professional reported that after vaccination with 3 doses of TWINRIX, they tested the levels and the patient was positive for Hepatitis A titers but was borderline for Hepatitis B titers. Thus leading the patient to be a therapy non-responder. So they gave a booster dose of the Merck brand Hepatitis B in February 2014 and they re-drew the levels in June of the reporting year and the patient was still borderline for Hepatitis B titers. Thus, again leading the patient to be therapy non-responder. It was unclear if the reported batch number AHABB251AA for TWINRIX corresponded 1st, 2nd or 3rd dose of the vaccine or it belongs to all doses of vaccine. Lab Comments: On unknown date, the patient underwent hepatitis A antibody and hepatitis B antibody test.
Went to eye doctor = pt thought she had another stye, but eye doctor told her he thought it was shingles because it was past the crease in her eye for another stye. Resolved now.
Patient reports having intermittent dizziness day 4 of 2nd Moderna vaccine.  Was also suffering from allergies at the same time.  Dizziness lasted one day and then re occurred one week later.
This spontaneous report as received from a pharmacist refers to a male patient in mid fifties. On 28-OCT-2014 the patient was vaccinated with a dose of ZOSTAVAX, 0.65 ml, subcutaneous. On an unknown date in 2014, after vaccination, the patient developed fluid filled vesicles around injection site. On an unknown date the patient was "screened for allergies like gelatin and neomycin" so no allergies related to ZOSTAVAX ingredients. No treatment was given for the adverse event. The patient sought medical attention and contacted with the physician. The outcome of fluid filled vesicles was reported as not recovered/not resolved. The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
Pt was inadvertenly given the Moderna monovalent vaccine instead of the Moderna bivalent booster.  He is scheduled to return to receive the Moderna bivalent vaccine.
Left shoulder joint pain with certain motions, such as putting on coat. As of 11/19/14 he is still having pain in joint area.